Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Reviewed transaction comps tagged cpg, including disclosed, estimated and rumored values where source notes or calculation basis are available.
67
Reviewed transactions
50
With price data
4.3x
Median EV or valuation / revenue
17.2x
Median EV or valuation / EBITDA
Sortable transaction comps
CPG transaction table
Rows with reported value
51 / 67
Acquisition value, USD
USD 57B
Investment capital, USD
USD 362M
Median EV or valuation / revenue
4.3x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
67 shown of 67 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| DeBeukelaer Corporation Control (2%) | - | Griesson-de Beukelaer | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| MADE Group Control (49%) | - | Danone | Undisclosed | Undisclosed | - | - | Australia | Confirmed 1 source | ||
| The European Candy Group B.V. Control (100%) | 2026-07-31 | Orkla Snacks (Orkla ASA) | EUR 207M Enterprise Value | 235 | 1.9x | 9.9x | Netherlands (Drachten; facilities in Netherlands and Germany) | Confirmed 1 source | ||
| Huel Control (100%) | 2026-03-23 | Danone | EUR 1.0B Enterprise Value | 1,160 | 3.5x | 34.8x | United Kingdom | Estimated 3 sources | ||
| Beautynova Control | 2024-03-18 | PAI Partners | EUR 330M | 365 | 2.5x | 10.6x | Italy | Estimated 1 source | ||
| Ultra Violette Capital Raise | 2024-01-23 | Aria Growth Partners | AUD 15.0M Investment Amount | 10 | - | - | Australia | Confirmed 1 source | ||
| RoC Skincare Control | 2024-01-23 | Bridgepoint | EUR 462M | 511 | 3.3x | 20.0x | - | Estimated 1 source | ||
| Dr. Barbara Sturm Control | 2024-01-01 | Puig | EUR 320M | 354 | 5.0x | - | - | Estimated 2 sources | ||
| Go-To Skincare Control | 2023-12-15 | Zoë Foster Blake | AUD 21.8M Consideration | 15 | - | - | Australia | Confirmed 1 source | ||
| Straand Capital Raise | 2023-12-10 | Unilever Ventures | USD 4.0M Investment Amount | 4 | - | - | Australia | Confirmed 1 source | ||
| Bonafide Health Control | 2023-11-30 | Pharmavite | USD 425M Consideration | 425 | - | - | - | Confirmed 1 source | ||
| COSRX Control (38%) | 2023-10-30 | Amorepacific | USD 1.0B | 1,000 | 3.6x | - | South Korea | Confirmed 2 sources | ||
| La Rosée Minority (20%) | 2023-09-09 | FG Bros | EUR 250M Investment Amount | 268 | 4.5x | 14.2x | - | Confirmed 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Bondi Sands Control | 2023-08-01 | Kao Corporation | AUD 450M Consideration | 298 | 4.2x | - | Australia | Confirmed 1 source | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| Aesop Control | 2023-04-03 | L’Oréal | EUR 2.2B Consideration | 2,500 | 4.4x | 24.7x | Australia | Confirmed 2 sources | ||
| Mielle Organics Control | 2023-01-11 | P&G Beauty | EUR 595M | 639 | 5.6x | 22.0x | - | Confirmed 2 sources | ||
| Skinbetter Science Control | 2022-09-23 | L’Oréal | USD 858M | 858 | 8.2x | - | United States | Confirmed 1 source | ||
| Hero Cosmetics Control | 2022-09-06 | Church & Dwight | USD 630M Consideration | 630 | 5.5x | 14.0x | United States | Estimated 3 sources | ||
| Bucklebury Control | 2022-09-01 | Haleon | Undisclosed Undisclosed | Undisclosed | - | - | United Kingdom | Confirmed 1 source | ||
| Tata Harper Control | 2022-09-01 | Amorepacific | EUR 125M | 125 | 2.8x | 24.5x | United States | Confirmed 1 source | ||
| The Better Health Company Control | 2022-06-29 | Nestle | Undisclosed Undisclosed | Undisclosed | - | - | New Zealand | Estimated 2 sources | ||
| Youtheory Control (95%) | 2022-06-01 | Jamieson Wellness Inc. | Undisclosed | Undisclosed | 1.8x | 10.0x | North America | Confirmed 1 source | ||
| Nutrafol Control | 2022-05-30 | Unilever | Undisclosed Undisclosed | Undisclosed | 4.9x | 22.7x | - | Confirmed 1 source | ||
| NAK Hair Control | 2022-05-01 | Adamantem Capital | AUD 90.0M | 65 | 2.3x | - | Australia | Estimated 1 source | ||
| Orgain Control | 2022-02-02 | Nestlé Health Science | Undisclosed | Undisclosed | 1.5x | 22.0x | United States | Confirmed 1 source | ||
| Ilia Beauty Control | 2022-02-01 | Courtin-Clarins family / Clarins | EUR 612M | 689 | 7.0x | 20.0x | - | Estimated 2 sources | ||
| Chantecaille Control | 2021-12-21 | Beiersdorf | EUR 609M | 688 | 4.6x | 15.3x | - | Confirmed 1 source | ||
| Supergoop Control | 2021-12-20 | Blackstone | EUR 618M | 697 | 5.8x | - | United States | Confirmed 1 source | ||
| ALASTIN Skincare Control | 2021-11-29 | Galderma | Undisclosed Undisclosed | Undisclosed | - | 8.6x | United States | Estimated 1 source | ||
| Sol de Janeiro Control (83%) | 2021-11-15 | L'Occitane | USD 450M | 450 | 7.5x | 21.1x | United States | Estimated 3 sources | ||
| Obagi Control | 2021-11-15 | Waldencast | EUR 756M | 865 | 4.5x | 17.2x | - | Confirmed 1 source | ||
| Milk Makeup Control | 2021-11-15 | Waldencast Acquisition Corp. | EUR 337M | 386 | 5.8x | - | US (NY) | Estimated 1 source | ||
| Uqora Control | 2021-07-08 | Pharmavite | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Paula's Choice Control | 2021-06-14 | Unilever | USD 2.0B | 2,000 | 6.7x | 18.0x | - | Estimated 1 source | ||
| Bentley Laboratories Control | 2021-05-11 | THG | USD 255M | 255 | - | 17.0x | New Jersey, United States | Estimated 1 source | ||
| 2021-04-30 | Nestlé | USD 5.8B Consideration | 5,750 | 3.1x | 16.8x | - | Confirmed 1 source | |||
| Vegamour Minority | 2021-04-13 | General Atlantic | USD 80.0M Investment Amount | 80 | 3.0x | 15.0x | - | Confirmed 1 source | ||
| Go-To Skincare Control (50%) | 2021-03-01 | BWX | AUD 178M | 138 | 4.8x | 14.9x | Australia | Estimated 2 sources | ||
| Microbiome Labs Control | 2021-01-06 | Novozymes | USD 125M Consideration | 125 | 3.1x | 6.0x | United States | Confirmed 1 source | ||
| Smarty Pants Control | 2020-11-25 | Unilever | Undisclosed | Undisclosed | 4.0x | - | - | Confirmed 1 source | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| Cremo Control | 2020-08-04 | Edgewell Personal Care | USD 235M Consideration | 235 | 4.1x | - | US | Confirmed 1 source | ||
| Thayers Natural Remedies Control | 2020-06-18 | L'Oréal | USD 400M Rumored Value | 400 | 7.3x | 13.3x | - | Estimated 1 source | ||
| Vital Proteins Control | 2020-06-10 | Nestlé Health Science | Undisclosed | Undisclosed | 4.3x | - | - | Confirmed 1 source | ||
| 2020-02-01 | ADM | Undisclosed | Undisclosed | - | - | Brazil | Unknown 1 source | |||
| Dr. Jart+ Control (33%) | 2019-11-18 | The Estée Lauder Companies | USD 1.9B | 1,902 | 3.8x | - | South Korea | Estimated 1 source | ||
| Quest Nutrition Control | 2019-08-22 | The Simply Good Foods Company | USD 1.0B Consideration | 1,000 | 2.9x | 17.4x | United States | Estimated 1 source | ||
| Filorga Control | 2019-07-11 | Colgate-Palmolive | EUR 1.5B Equity Purchase Price | 1,690 | 8.3x | - | France | Confirmed 4 sources | ||
| Tatcha Control | 2019-06-10 | Unilever | USD 500M Rumored Value | 500 | 5.0x | - | - | Estimated 1 source | ||
| Ranir Global Holdings LLC Control | 2019-05-09 | Perrigo | USD 750M Consideration | 750 | 2.6x | - | Grand Rapids, Michigan, United States | Estimated 1 source | ||
| OLLY Nutrition Control | 2019-04-18 | Unilever | Undisclosed Undisclosed | Undisclosed | 5.0x | 20.0x | United States | Confirmed 1 source | ||
| Ci:z Holdings Co., Ltd. Control | 2018-10-23 | Johnson & Johnson | USD 2.1B | 2,100 | 4.5x | 22.0x | Japan | Confirmed 1 source | ||
| First Aid Beauty Control | 2018-07-17 | P&G | USD 250M Rumored Value | 250 | 4.5x | - | US | Estimated 1 source | ||
| Probiotics International Control | 2018-07-02 | ADM | USD 243M Consideration | 243 | 5.6x | 21.2x | United Kingdom | Estimated 2 sources | ||
| Nutranext Control | 2018-03-12 | Clorox | USD 700M Consideration | 700 | 3.5x | 14.0x | - | Estimated 1 source | ||
| PCA Skin and EltaMD Control | 2017-12-18 | Colgate-Palmolive | USD 730M | 730 | 7.3x | - | - | Estimated 1 source | ||
| Atrium Innovations Control | 2017-12-05 | Nestlé | USD 2.3B Consideration | 2,300 | 3.3x | 19.0x | - | Confirmed 1 source | ||
| Obagi Medical Products Business Control | 2017-07-01 | Haitong International Zhonghua Finance Acquisition Fund I, L.P. | USD 190M | 190 | 2.2x | 6.3x | - | Confirmed 1 source | ||
| Nutraceutical Control | 2017-05-22 | HGGC | Undisclosed | Undisclosed | 1.8x | 9.9x | - | Confirmed 1 source | ||
| Mead Johnson Nutrition Control | 2017-02-10 | Reckitt Benckiser | USD 17B Consideration | 16,600 | 4.8x | 17.6x | - | Confirmed 1 source | ||
| Viviscal Control | 2017-01-20 | Church & Dwight | Undisclosed | Undisclosed | 3.6x | 17.8x | - | Confirmed 1 source | ||
| CeraVe, AcneFree, Ambi Control | 2017-01-10 | L'Oréal | USD 1.3B | 1,300 | 7.7x | - | - | Confirmed 1 source | ||
| Vitaco Control | 2016-08-01 | Primavera Capital | Undisclosed | Undisclosed | 1.5x | 14.7x | Australia/New Zealand | Confirmed 1 source | ||
| Dollar Shave Club, Inc. Control | 2016-07-20 | Unilever | USD 1.0B Consideration | 1,000 | 6.6x | - | US | Confirmed 1 source | ||
| Swisse Control (3%) | 2015-09-17 | Biostime | USD 1.7B Consideration | 1,670 | - | 15.5x | Australia | Confirmed 1 source |
FundComb transaction comps are informational only. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.